?:authorAffiliation
|
-
[\'Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), 1649-016 Lisbon, Portugal.\', \'Local Coordination Group for the Prevention and Control of Infections and Antimicrobial Resistance Program, Vila Franca de Xira Hospital, 2600-009 Vila Franca de Xira, Portugal.\', \'Clinical Pathology Department, Vila Franca de Xira Hospital, 2600-009 Vila Franca de Xira, Portugal.\', \'Clinical Department, Vila Franca de Xira Hospital, 2600-009 Vila Franca de Xira, Portugal.\', \'Internal Medicine Department, Vila Franca de Xira Hospital, 2600-009 Vila Franca de Xira, Portugal.\', \'Public Health Authority, Regional Health Administration of Lisbon and Tagus Valley, Health Centers Groups of Tagus Valley, 2615-042 Alverca do Ribatejo, Portugal.\', \'Innovation and Technology Unit, Department of Human Genetics, National Institute of Health Doutor Ricardo Jorge (INSA), 1649-016 Lisbon, Portugal.\', \'Centre for Toxicogenomics and Human Health (ToxOmics), Genetics, Oncology and Human Toxicology, Nova Medical School|Faculdade de Ciências Médicas, Universidade Nova de Lisboa, 1649-016 Lisbon, Portugal.\', \'National Reference Laboratory for Influenza and Other Respiratory Viruses, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), 1649-016 Lisbon, Portugal.\']
|